Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

BACKGROUND: Subcutaneous administration of Ig (SCIg) has gained popularity as an alternative route of administration but has never been rigorously examined in chronic inflammatory demyelinating polyneuropathy (CIDP). METHODS/DESIGN: The primary objective of the PATH study (Polyneuropathy and Treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schaik, Ivo N., van Geloven, Nan, Bril, Vera, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Mielke, Orell, Cornblath, David R., Merkies, Ingemar S. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960813/
https://www.ncbi.nlm.nih.gov/pubmed/27455854
http://dx.doi.org/10.1186/s13063-016-1466-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960813/
https://www.ncbi.nlm.nih.gov/pubmed/27455854
http://dx.doi.org/10.1186/s13063-016-1466-2

Ejemplares similares